Operating profit to grow again ahead of Sandoz spin off: Novartis Ruchika Sharma1 Feb 2023 4:30 AM GMTNovartis said in its statement it's on track to spin off its generics unit Sandoz in the second half of the year as part of its effort to sharpen its...
Vaccine-preventable Infections andImmunization in Multiple Sclerosis: Practice Guideline Update Dr. Kamal Kant Kohli30 Jan 2023 5:00 AM GMTAmerican Academy of Neurology (AAN) has released guidelines titled Vaccine-preventable Infections and Immunization in Multiple Sclerosis in September...
Insufficient good quality sleep during adolescence may raise subsequent risk of multiple sclerosis: BMJ Dr. Kamal Kant Kohli27 Jan 2023 4:30 AM GMTSweden: A recent case-control study has found that low sleep quality and insufficient sleep during the teenage years increase the risk of subsequent...
Medical Bulletin 25/January/2023 Isra Zaman25 Jan 2023 9:15 AM GMTHere are the top medical news for the day:Poor sleep during teenage years may increase subsequent MS risk: Study Insufficient and disturbed sleep...
Poor sleep during teenage years may increase subsequent MS risk: Study Isra Zaman25 Jan 2023 3:30 AM GMTInsufficient and disturbed sleep during the teenage years may heighten the subsequent risk of multiple sclerosis (MS), suggests a case-control study...
Medical Bulletin 20/January/2023 Isra Zaman20 Jan 2023 10:35 AM GMTHere are the top medical news for the day:Irritable bowel syndrome linked to lower bacterial diversity: StudyPeople with irritable bowel syndrome...
Connection between multiple sclerosis lesions and depression uncovered Isra Zaman20 Jan 2023 4:15 AM GMTTwo major health conditions appear to share a connection. Multiple sclerosis (MS), a disease which eats away at the body’s central nervous system,...
Light therapy relieves fatigue syndrome in Multiple Sclerosis Dr. Kamal Kant Kohli6 Jan 2023 4:00 AM GMTMultiple Sclerosis (MS) is almost always accompanied by fatigue, a massive tiredness that is described by the vast majority of patients as the most...
Medical Bulletin 30/December/2022 Isra Zaman30 Dec 2022 5:00 AM GMTHere are the top medical news for the day:Based on ULTIMATE I & II trial results, novel drug BRIUMVI gets USFDA approval for relapsing forms of...
Based on ULTIMATE I & II trial results, novel drug BRIUMVI gets USFDA approval for relapsing forms of multiple sclerosis patients Isra Zaman30 Dec 2022 3:30 AM GMTTG Therapeutics recently announced the U.S.Food and Drug Administration (FDA) has approved BRIUMVI (ublituximab-xiiy),for the treatment of relapsing...
Medical Bulletin 17/December/2022 Isra Zaman17 Dec 2022 8:45 AM GMTHere are the top medical news for the day:New, safer treatment for serious side effect of bone marrow transplant identifiedThe clinical trial in...
Multiple sclerosis condition may be affected by gut health and diet Isra Zaman17 Dec 2022 4:45 AM GMTMS is a degenerative condition in which the body's immune system attacks the protective covering of nerves in the brain, spinal cord and eyes....
